We read with great interest the article entitled ‘Classification of Raynaud’s disease
based on angiographic features.’
1
We congratulate the authors for attempting to rationalise their previous surgical
practice in managing digital ischaemia in the hand into a treatment-oriented classification.
Whilst we believe that this approach may improve the treatment of patients with symptoms
refractory to medical measures, we believe that the algorithm is incomplete, and not
adequately justified.To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of Plastic, Reconstructive & Aesthetic SurgeryAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Classification of Raynaud’s disease based on angiographic features.J Plast Reconstr Aesthet Surg. 2011; 64: 1503-1511
- Botox therapy for ischemic digits.Plast Reconstr Surg. 2009; 124: 191-201
- Management of vasospastic disorders with botulinum toxin A.Plast Reconstr Surg. 2007; 119: 217-226
- Botulinum toxin type A: a treatment option for digital ischemia in patients with Raynaud’s phenomenon.J Hand Surg Am. 2009; 34: 446-452
Article info
Publication history
Published online: February 14, 2012
Identification
Copyright
© 2012 Published by Elsevier Inc.
ScienceDirect
Access this article on ScienceDirectLinked Article
- Classification of Raynaud’s disease based on angiographic features: Rationalising treatmentJournal of Plastic, Reconstructive & Aesthetic SurgeryVol. 65Issue 7
- PreviewWe thank Dr Dariush Nikkhah and his co-authors for their interest in our article entitled ‘Classification of Raynaud’s disease based on angiographic features’.1 They have suggested including botulinum therapy in the treatment algorithm for chronic intractable ischaemic digits resulting from Raynaud’s disease.
- Full-Text
- Preview
